KRMD Repro Med Systems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: KRMD

Price (delayed)

$3.27

Market cap

$150.98M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$146M

?
Relative Growth: Rel. Growth: 59
Relative Strength: Rel. Strength: 13
Relative Valuation: Rel. Valuation: 15
Relative Profitability: Rel. Profitability: 42

REPRO-MED Systems, Inc. (REPRO-MED) designs, manufactures, and markets medical devices primarily for the ambulatory infusion market and emergency medical applications. The Company's development and marketing focus are primarily concentrated on ...

Highlights
The net income has surged by 60% year-on-year and by 20% since the previous quarter
KRMD's EPS has surged by 56% year-on-year and by 20% since the previous quarter
The quick ratio has grown by 18% from the previous quarter but it has contracted by 8% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.korumedical.com
Peers: OFIX

Key stats

What are the main financial stats of KRMD

KRMD stock price

How has the Repro Med Systems stock price performed over time
Intraday
-1.21%
1 week
2.19%
1 month
1.87%
1 year
-18.86%
YTD
-43.72%
QTD
-22.14%

Financial performance

How have Repro Med Systems's revenue and profit performed over time
Revenue
$45.11M
Gross profit
$28.16M
Operating income
-$1.65M
Net income
-$1.82M
Gross margin
62.4%
Net margin
-4%
The company's operating margin has surged by 72% YoY and by 38% QoQ
KRMD's net margin has surged by 67% year-on-year and by 25% since the previous quarter
KRMD's operating income has soared by 66% YoY and by 36% from the previous quarter
The net income has surged by 60% year-on-year and by 20% since the previous quarter

Price vs fundamentals

How does KRMD's price correlate with its fundamentals

Growth

What is Repro Med Systems's growth rate over time

Valuation

What is Repro Med Systems stock price valuation
P/E
N/A
P/B
8.32
P/S
3.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.24
KRMD's EPS has surged by 56% year-on-year and by 20% since the previous quarter
KRMD's price to book (P/B) is 32% lower than its last 4 quarters average of 12.3 but 20% higher than its 5-year quarterly average of 7.0
The company's equity rose by 9% YoY and by 7% QoQ
The P/S is 32% below the last 4 quarters average of 5.0 and 30% below the 5-year quarterly average of 4.8
The revenue has grown by 22% YoY and by 4.3% from the previous quarter

Efficiency

How efficient is Repro Med Systems business performance
KRMD's return on sales has surged by 67% year-on-year and by 23% since the previous quarter
Repro Med Systems's return on assets has surged by 61% YoY and by 22% QoQ
Repro Med Systems's ROE has soared by 60% YoY and by 22% from the previous quarter
KRMD's return on invested capital has surged by 59% year-on-year and by 20% since the previous quarter

Dividends

What is KRMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KRMD.

Financial health

How did Repro Med Systems financials performed over time
The total assets is 182% more than the total liabilities
The quick ratio has grown by 18% from the previous quarter but it has contracted by 8% YoY
The current ratio has grown by 17% from the previous quarter but it has contracted by 7% YoY
KRMD's debt is 82% smaller than its equity
The debt to equity fell by 14% YoY and by 10% QoQ
The company's equity rose by 9% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.